Jankowski, Orion D.,Hinman, Andrew W.,Miller, Guy M.
申请号：
AU2011285619
公开号：
AU2011285619A1
申请日:
2011.08.04
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
Methods of treating, preventing or suppressing symptoms associated with mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), dominant optic atrophy (DOA)； mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), Leigh syndrome or Kearns-Sayre Syndrome (KSS) with compounds of Formula (I) are disclosed. Methods of modulating, normalizing, or enhancing energy biomarkers, as well as compounds useful for such methods are also disclosed.
